...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Annual Financial Reporting

"We will never know why Shawn Lu resigned. "

I respectfully disagree , IMO somethings in the works where by making that seat available for the new comer(s)/money people, scientist , high end Pharma exec etc.

"HL converting debentures to common shares may not be all that bad and dethroning DM in the process..Beats HL taking possession of the IPs."

Wouldn't HL reach the majic number just by converting thus taking control of the IPs anyway?

plus we talked about how much dilution would occur with a 50--100 million dollar raise to get this thing going.

Again the best & only hope we have  to not totally dilute & destroy rvx is a Zenith deal, it's the only out that makes any sense to me. Not sure how Don feels at his age moving towards his eighty's about wanting or needing another 5-10 years of this BS.

Anyway things should be much more transparent within the next month or so max,hopefully!!

glta 

 

Share
New Message
Please login to post a reply